Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,079 public trials 2,046 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

NCT01383928

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: UCSF Medical Center Berkeley, California, United States

City of Hope National Medical Center Duarte, California, United States

Stanford University Stanford, California, United States

H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View all 20 locations

View Trial Details

Completed

Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma

NCT01556438

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan

View Trial Details

Completed

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

NCT00807599

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan Kettering West Harrison Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Study Evaluating The Safety And Tolerability Of Combination Therapy Inotuzumab Ozogamicin (CMC-544) And Rituximab

NCT00724971

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Nagoya Daini Red Cross Hospital Aichi, Japan

Tokai University Hospital Kanagawa, Japan

National Cancer Center Hospital Tokyo, Japan

Cancer Inst. Hp. of Japanese Foundation for Cancer Research Tokyo, Japan

View Trial Details

Completed

A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas

NCT01512758

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: National Cancer Centre Tiong Bahru, Singapore

View Trial Details

Completed

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

NCT00796562

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +12 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Evaluation of Cardiotoxic Effects of Bortezomib

NCT02026505

Conditions: Blood Protein Disorders, Cardiotoxins, Cardiovascular Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT02497378

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hiroshima, Japan

Hitachi, Japan

Nagoya, Japan

Shibuya City, Japan

View Trial Details

Completed

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

NCT00552955

Conditions: Ascites, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +27 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Intravenous Immunoglobulin (IVIG) in Lung Transplantation

NCT00115778

Conditions: Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +7 more
Locations: New York Presbyterian Hospital Lung Transplant Program New York, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions